Genotypic and phenotypic spectrum of <i>PANK2</i> mutations in patients with neurodegeneration with brain iron accumulation

Abstract

Deletion screening of PANK2 should be part of the diagnostic spectrum. Factors other than enzymatic residual activity are determining the course of disease. There are strong arguments in favor of locus heterogeneity.